David A. Siegel Xencor Inc Call Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XNCR
# of Institutions
203Shares Held
64MCall Options Held
2.2KPut Options Held
1.3K-
Black Rock Inc. New York, NY11.1MShares$209 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA9.09MShares$172 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.01MShares$133 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$101 Million3.36% of portfolio
-
State Street Corp Boston, MA4.24MShares$80.2 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.13B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...